These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8769708)

  • 1. Autografting for CML--overview and perspectives.
    Goldman JM
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S71-4. PubMed ID: 8769708
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic myeloid leukemia. New prospects for marrow autotransplantation].
    Carella AM; Carlier P; Nati S; Congiu A; Pierluigi D; Raffo MR
    Haematologica; 1991 Jun; 76 Suppl 3():337-51. PubMed ID: 1684348
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of autotransplants in chronic myeloid leukaemia.
    Goldman JM; Deisseroth AB
    Bone Marrow Transplant; 1992; 10 Suppl 1():74-6. PubMed ID: 1355687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous bone marrow or peripheral blood stem cell transplantation for patients with chronic myelogenous leukaemia in chronic phase.
    Meloni G; De Fabritiis P; Alimena G; Malagnino F; Montefusco E; Sandrelli A; Pinto R; Vignetti M; Lo Coco F; Mandelli F
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():92-4. PubMed ID: 2576389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferon alpha in the treatment of chronic myeloid leukemia. Promises, realities, and perspectives].
    Steegmann JL; Granados E; Rodríguez-Salvanés F; Casado LF; Giraldo P; Lavilla E; Gómez-Casares MT; Fernández-Contreras E; Odriozola J
    Sangre (Barc); 1998 Apr; 43(2):137-46. PubMed ID: 9656775
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia.
    Zuffa E; Bandini G; Bonini A; Santucci MA; Martinelli G; Rosti G; Testoni N; Zaccaria A; Tura S
    Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autografting for CML--where does it fit in to the overall treatment strategy?
    Goldman JM
    Bone Marrow Transplant; 1994; 14 Suppl 3():S74-7. PubMed ID: 7697014
    [No Abstract]   [Full Text] [Related]  

  • 9. [Initial treatment of chronic myelogenous leukemia--interferon or bone marrow transplantation].
    Urabe A
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1381-6. PubMed ID: 10500523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collection of Ph-negative progenitor cells from Ph+ CML patients in complete cytogenetic remission after long-term interferon-alpha therapy.
    Russo D; Martinelli G; Montefusco V; Amabile M; Rosti G; Marin L
    Haematologica; 1999 Oct; 84(10):953-5. PubMed ID: 10509048
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic myeloid leukemia: progress and prospects].
    Baccarani M; Russo D; Fanin R
    Haematologica; 1991 Jun; 76 Suppl 3():40-5. PubMed ID: 1752539
    [No Abstract]   [Full Text] [Related]  

  • 12. No known cause: leukemia research.
    Tecnologica; 2000; ():1, 3-6, 14. PubMed ID: 11010680
    [No Abstract]   [Full Text] [Related]  

  • 13. Autologous bone marrow transplantation in chronic myeloid leukaemia.
    Divya
    Natl Med J India; 1998; 11(1):19-21. PubMed ID: 9557515
    [No Abstract]   [Full Text] [Related]  

  • 14. Update on therapy for chronic myelogenous leukemia.
    Weinberger BB
    J La State Med Soc; 1994 Aug; 146(8):341-3. PubMed ID: 7930864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
    Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unsuccessful allogeneic and autologous transplants after prolonged interferon-alpha treatment in a pediatric patient with chronic myeloid leukemia.
    Pérez-Caballero C; Maldonado MS; Tamariz R; de Oteyza JP; Muñoz A
    Haematologica; 2000 Jan; 85(1):105-6. PubMed ID: 10629605
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclophosphamide/GM-CSF priming in autotransplant therapy for CML.
    McGlave P; Bhatia R; Verfaillie C
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S65-6. PubMed ID: 8769706
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent progress in therapy for chronic myelogenous leukemia].
    Urabe A
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1066-73. PubMed ID: 9239158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autologous hemopoietic stem cell transplantation in treatment of chronic myelogenous leukemia].
    Sacha T; Hawrylecka D; Skotnicki AB
    Przegl Lek; 1999; 56 Suppl 1():62-6. PubMed ID: 10494185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. t(3;21) following peripheral blood stem cell transplantation in chronic phase chronic myeloid leukaemia.
    Jacob A; Griffiths M; Larkins S; Holmes J
    Bone Marrow Transplant; 1997 Jun; 19(12):1255-8. PubMed ID: 9208122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.